Annual report pursuant to Section 13 and 15(d)

Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details)

v3.23.1
Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 147,707 20,156
Non-vested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 1,375,145 717,097
Non-vested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 392,564  
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share    
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 240,100 240,100